Shares of chemical company Croda International CRDA.L up nearly 1% at 2,614p
J.P.Morgan upgrades CRDA to "overweight" from "neutral"; maintains PT 3,600p
Brokerage sees FY25–27 consensus on adjusted EPS growth to about 187.4p from nearly 145.6p as achievable
"Company is implementing a multi-year growth and efficiency transformation program to improve earnings delivery and returns. We see significant room for cost efficiency and working capital improvements" - brokerage
On Tuesday, Croda reported first-half sales slightly below estimate
On avg, stock rated "hold" by 13 analysts; median PT is 3,440p - data compiled by LSEG
As of last close, the stock is down about 23% this year